Table 2.

Nine Human Height-Related Genetic Variants Associated With FSS Risk

Training Group (Participant 930 and Control: 856)Testing Group (Participant 233 and control: 215)Total groups (Participant 1,163 and control: 1,071)
Genetic Variant (rs ID)GeneChrPositionRisk AlleleReferencePMID NumberPopulationOR 95% CIP ValueOR 95% CIp valueOR 95% CIp value
rs2421992DNM31172241251C Wood AR et al, 201425282103European4.35(3.85-5.00)5.72E-935.00(3.7 - 6.67)1.37E-274.55(4.00 - 5.00)8.78E-119
rs4974480ANAPC133134178562A Wood AR et al, 201425282103European1.33(1.14-1.54)3.05E-041.55(1.15 - 2.10)4.33E-031.37(1.20 - 1.57)6.21E-06
rs13131350LCORL417877487GHe M et al, 201525429064European, East Asian1.30(1.12-1.49)3.92E-041.40(1.06 - 1.85)1.83E-021.32(1.16 - 1.50)2.31E-05
rs7763064GPR1266142797289A Lango Allen H et al, 201020881960European1.23(1.07-1.41)3.26E-031.19(0.91 - 1.55)1.99E-011.22(1.08 - 1.38)1.36E-03
rs10858250QSOX29139119215AHe M et al, 201525429064European, East Asian1.23(1.05-1.45)8.53E-031.37(1.00 - 1.85)5.08E-021.27(1.10 - 1.47)1.21E-03
rs11170631ATF7-ATP5G21254041192T Okada Y et al, 201020189936Japanese1.35(1.18-1.56)1.57E-051.43(1.09 - 1.89)1.18E-021.37(1.20 - 1.56)6.08E-07
rs258324CDK101689754255GHe M et al, 201525429064East Asian1.19(1.03-1.39)1.61E-021.32(0.99 - 1.79)6.14E-021.22(1.08 - 1.39)2.80E-03
rs8094261CABLES11820746728G Kim JJ et al, 201019893584Korean1.38(1.16-1.64)2.57E-041.33(0.94 - 1.88)1.05E-011.37(1.17 - 1.6)6.46E-05
rs4911494UQCC12033971914T Soranzo N et al, 200919343178European1.33(1.15-1.54)1.26E-041.22(0.89 - 1.67)2.08E-011.32(1.15 - 1.49)6.12E-05
Training Group (Participant 930 and Control: 856)Testing Group (Participant 233 and control: 215)Total groups (Participant 1,163 and control: 1,071)
Genetic Variant (rs ID)GeneChrPositionRisk AlleleReferencePMID NumberPopulationOR 95% CIP ValueOR 95% CIp valueOR 95% CIp value
rs2421992DNM31172241251C Wood AR et al, 201425282103European4.35(3.85-5.00)5.72E-935.00(3.7 - 6.67)1.37E-274.55(4.00 - 5.00)8.78E-119
rs4974480ANAPC133134178562A Wood AR et al, 201425282103European1.33(1.14-1.54)3.05E-041.55(1.15 - 2.10)4.33E-031.37(1.20 - 1.57)6.21E-06
rs13131350LCORL417877487GHe M et al, 201525429064European, East Asian1.30(1.12-1.49)3.92E-041.40(1.06 - 1.85)1.83E-021.32(1.16 - 1.50)2.31E-05
rs7763064GPR1266142797289A Lango Allen H et al, 201020881960European1.23(1.07-1.41)3.26E-031.19(0.91 - 1.55)1.99E-011.22(1.08 - 1.38)1.36E-03
rs10858250QSOX29139119215AHe M et al, 201525429064European, East Asian1.23(1.05-1.45)8.53E-031.37(1.00 - 1.85)5.08E-021.27(1.10 - 1.47)1.21E-03
rs11170631ATF7-ATP5G21254041192T Okada Y et al, 201020189936Japanese1.35(1.18-1.56)1.57E-051.43(1.09 - 1.89)1.18E-021.37(1.20 - 1.56)6.08E-07
rs258324CDK101689754255GHe M et al, 201525429064East Asian1.19(1.03-1.39)1.61E-021.32(0.99 - 1.79)6.14E-021.22(1.08 - 1.39)2.80E-03
rs8094261CABLES11820746728G Kim JJ et al, 201019893584Korean1.38(1.16-1.64)2.57E-041.33(0.94 - 1.88)1.05E-011.37(1.17 - 1.6)6.46E-05
rs4911494UQCC12033971914T Soranzo N et al, 200919343178European1.33(1.15-1.54)1.26E-041.22(0.89 - 1.67)2.08E-011.32(1.15 - 1.49)6.12E-05

OR calculation was conducted according to the defined risk alleles. Deviation from the additive model was tested. A P value for the additive test < 0.05 in the training group was considered significant.

Abbreviations: Chr, chromosome; CI, confidence interval; FSS, familial short stature; ID, identifier; PMID, PubMed identifier; OR, odds ratio.

Table 2.

Nine Human Height-Related Genetic Variants Associated With FSS Risk

Training Group (Participant 930 and Control: 856)Testing Group (Participant 233 and control: 215)Total groups (Participant 1,163 and control: 1,071)
Genetic Variant (rs ID)GeneChrPositionRisk AlleleReferencePMID NumberPopulationOR 95% CIP ValueOR 95% CIp valueOR 95% CIp value
rs2421992DNM31172241251C Wood AR et al, 201425282103European4.35(3.85-5.00)5.72E-935.00(3.7 - 6.67)1.37E-274.55(4.00 - 5.00)8.78E-119
rs4974480ANAPC133134178562A Wood AR et al, 201425282103European1.33(1.14-1.54)3.05E-041.55(1.15 - 2.10)4.33E-031.37(1.20 - 1.57)6.21E-06
rs13131350LCORL417877487GHe M et al, 201525429064European, East Asian1.30(1.12-1.49)3.92E-041.40(1.06 - 1.85)1.83E-021.32(1.16 - 1.50)2.31E-05
rs7763064GPR1266142797289A Lango Allen H et al, 201020881960European1.23(1.07-1.41)3.26E-031.19(0.91 - 1.55)1.99E-011.22(1.08 - 1.38)1.36E-03
rs10858250QSOX29139119215AHe M et al, 201525429064European, East Asian1.23(1.05-1.45)8.53E-031.37(1.00 - 1.85)5.08E-021.27(1.10 - 1.47)1.21E-03
rs11170631ATF7-ATP5G21254041192T Okada Y et al, 201020189936Japanese1.35(1.18-1.56)1.57E-051.43(1.09 - 1.89)1.18E-021.37(1.20 - 1.56)6.08E-07
rs258324CDK101689754255GHe M et al, 201525429064East Asian1.19(1.03-1.39)1.61E-021.32(0.99 - 1.79)6.14E-021.22(1.08 - 1.39)2.80E-03
rs8094261CABLES11820746728G Kim JJ et al, 201019893584Korean1.38(1.16-1.64)2.57E-041.33(0.94 - 1.88)1.05E-011.37(1.17 - 1.6)6.46E-05
rs4911494UQCC12033971914T Soranzo N et al, 200919343178European1.33(1.15-1.54)1.26E-041.22(0.89 - 1.67)2.08E-011.32(1.15 - 1.49)6.12E-05
Training Group (Participant 930 and Control: 856)Testing Group (Participant 233 and control: 215)Total groups (Participant 1,163 and control: 1,071)
Genetic Variant (rs ID)GeneChrPositionRisk AlleleReferencePMID NumberPopulationOR 95% CIP ValueOR 95% CIp valueOR 95% CIp value
rs2421992DNM31172241251C Wood AR et al, 201425282103European4.35(3.85-5.00)5.72E-935.00(3.7 - 6.67)1.37E-274.55(4.00 - 5.00)8.78E-119
rs4974480ANAPC133134178562A Wood AR et al, 201425282103European1.33(1.14-1.54)3.05E-041.55(1.15 - 2.10)4.33E-031.37(1.20 - 1.57)6.21E-06
rs13131350LCORL417877487GHe M et al, 201525429064European, East Asian1.30(1.12-1.49)3.92E-041.40(1.06 - 1.85)1.83E-021.32(1.16 - 1.50)2.31E-05
rs7763064GPR1266142797289A Lango Allen H et al, 201020881960European1.23(1.07-1.41)3.26E-031.19(0.91 - 1.55)1.99E-011.22(1.08 - 1.38)1.36E-03
rs10858250QSOX29139119215AHe M et al, 201525429064European, East Asian1.23(1.05-1.45)8.53E-031.37(1.00 - 1.85)5.08E-021.27(1.10 - 1.47)1.21E-03
rs11170631ATF7-ATP5G21254041192T Okada Y et al, 201020189936Japanese1.35(1.18-1.56)1.57E-051.43(1.09 - 1.89)1.18E-021.37(1.20 - 1.56)6.08E-07
rs258324CDK101689754255GHe M et al, 201525429064East Asian1.19(1.03-1.39)1.61E-021.32(0.99 - 1.79)6.14E-021.22(1.08 - 1.39)2.80E-03
rs8094261CABLES11820746728G Kim JJ et al, 201019893584Korean1.38(1.16-1.64)2.57E-041.33(0.94 - 1.88)1.05E-011.37(1.17 - 1.6)6.46E-05
rs4911494UQCC12033971914T Soranzo N et al, 200919343178European1.33(1.15-1.54)1.26E-041.22(0.89 - 1.67)2.08E-011.32(1.15 - 1.49)6.12E-05

OR calculation was conducted according to the defined risk alleles. Deviation from the additive model was tested. A P value for the additive test < 0.05 in the training group was considered significant.

Abbreviations: Chr, chromosome; CI, confidence interval; FSS, familial short stature; ID, identifier; PMID, PubMed identifier; OR, odds ratio.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close